Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Dcoy Stock Analysis Biotech Decoy Therapeutics Inc. Rises 1.43 Percent To 6.62 Dollars 20260401 1 Hims Stock Analysis Hims And Hers Health 3.53 Dip Near 19.14 Key Support Level 20260403 Is Doximity Docs Stock Trading Below Intrinsic Value Price At 22.13 Down 1.64 20260408 Can Sofi Technologies Sofi Stock Reach New Highs Price At 16.24 Up 2.46 20260406 Will Obsidian Obe Stock Outperform S P 500 Price At 9.63 Up 6.41 20260413 Abivax ABVX Stock Worth Buying 081 20260416 RFAMU RF reports inaugural quarterly earnings as blankcheck company no operational revenue disclosed Venture VG Stock Trend Analysis Venture Global Inc posts 112 pct EPS beat on cost efficiency CoDiag CODX Stock Undervalued vs Overpriced 685 20260418 CantorEquity CEPT Stock Revenue Whisper 116 20260420 Toyota TM Stock Strength or Weakness Analysis Q1 2026 EPS Tops Views What Artiva Bio ARTV doing to improve profitability Q1 2026 Earnings Fall Short Newmont Corporation NEM National Bank Downgrade Reflects NearTerm Headwinds Amid Broad Bullish LongTerm Consensus IMCR Immunocore shares rise 156 percent on 289 percent Q4 2025 revenue growth despite wider than expected loss ABEV Ambev posts narrow Q4 2025 EPS beat shares rise 246 percent on upbeat investor reaction NVCT Nuvectis Pharma posts slight Q4 2025 EPS miss yet shares edge higher on positive investor sentiment FN Fabrinet Q1 2026 earnings narrowly beat estimates shares rise 337 percent on positive investor sentiment Blackrock HS BME Stock Volatility BME Latest Quarter Earnings Blackrock HS biotech portfolio outlook in focus with full metrics pending JPMorgan Chase Co JPM Bearish Risks Mount Following Aggressive Baker Hughes BKR Price Target Revision SPS Commerce SPSC Surges 228 Nearing 5366 Resistance 20260515 SANUWAVE Health SNWV Q1 2026 Results Miss Estimates EPS 018 vs 005 Inflation Figures Deteriorate Further as Latest Data Exceeds Prior Days Reading Lionsgates Michael Biopic Surpasses 700M Globally Topping Devil Wears Prada 2 Musk vs Altman Legal Battle Ends as IPO Showdown Looms for SpaceX and OpenAI GSK plc GSK Jumps 137 on Strong Momentum 20260518 What AtriCure ATRCs 119 Jump Means for Investors 20260518 PCConnection CNXN Climbs 160 Resistance at 6854 in Focus 20260518 Kalpataru Shangrila Infracon Tap Private Credit Funds for Debt Fundraise Report Chemung CHMG Q1 2026 Earnings Outperformance Signals Momentum Shuttle SHPH Declines 312 Amid Market Weakness 20260520 Aaron Carter Wrongful Death Lawsuit Raises Questions on Physician and Pharmacy Liability Money Market Account Rates TopYielding Accounts Offer 401 APY as of May 24 2026 AIDriven Drug Discovery May Accelerate Treatments for Brain Conditions Like MND Suzlon Energy Q4 FY2026 Profit Declines 6 Despite Robust Revenue Surge Paytm Block Deal Societe Generale Ghisallo Viridian Lead Buyers in Rs 964 Crore Stake Sale Fanatics Secures FIFA Exclusive License Bolstering Dominance in Sports Collectibles Market Newmark Group Inc NMRK Q1 2026 Earnings EPS Surprises to the Upside Shares Edge Higher RCUS Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick LPA Q1 2026 Earnings Net Loss Reported Amid Quiet Market Response GBTG Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency EWBC Q1 2026 Earnings EPS Surpasses Estimates Amid Solid Operating Performance LanzaTech Global LNZA Slides 72 as Resistance Holds Firm Key Support in Focus Revvity Inc RVTY Gains 165 as Price Approaches Key Resistance Pagaya Technologies PGY Slips 191 as Shares Test Key Support Zone Adagene Inc ADAG Presses Lower Support Test in Sight After 188 Decline What Above Food ABVE is doing that separates it from the herd Smart Money Exits 20260511 Is Suburban SPH stock worth evaluating for entry Steady Climb 20260420 RTX Corp RTX Q1 2026 Operational Strength Overshadowed by Commercial Aerospace Demand Concerns BofA Analysis Finds WOK WORK medical technology product lines gain steady traction boosting longterm growth outlook for the firm UDR UDR Q4 2025 EPS misses estimates by 476 percent 24 percent revenue gain sends stock down 134 percent